Insufficient scRNA-seq data for expression of GRID2IP at single-cell level.
Insufficient scRNA-seq data for expression of GRID2IP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 97% | 68.21 | 238 / 245 | 88% | 1.83 | 443 / 502 |
| pancreas | 99% | 68.38 | 324 / 328 | 68% | 1.40 | 121 / 178 |
| thymus | 100% | 59.11 | 651 / 653 | 65% | 1.04 | 395 / 605 |
| brain | 95% | 94.54 | 2498 / 2642 | 56% | 1.08 | 394 / 705 |
| ovary | 95% | 37.10 | 171 / 180 | 48% | 1.23 | 208 / 430 |
| lung | 86% | 27.78 | 497 / 578 | 54% | 1.16 | 623 / 1155 |
| stomach | 82% | 34.45 | 295 / 359 | 54% | 0.98 | 155 / 286 |
| bladder | 71% | 32.48 | 15 / 21 | 53% | 1.01 | 267 / 504 |
| intestine | 70% | 30.22 | 673 / 966 | 54% | 0.97 | 286 / 527 |
| breast | 75% | 43.93 | 342 / 459 | 43% | 0.75 | 479 / 1118 |
| esophagus | 60% | 31.27 | 872 / 1445 | 49% | 0.96 | 90 / 183 |
| kidney | 93% | 35.60 | 83 / 89 | 16% | 0.26 | 140 / 901 |
| adrenal gland | 97% | 97.71 | 251 / 258 | 11% | 0.28 | 26 / 230 |
| uterus | 86% | 23.56 | 146 / 170 | 20% | 0.35 | 91 / 459 |
| spleen | 97% | 34.91 | 233 / 241 | 0% | 0 | 0 / 0 |
| skin | 72% | 52.00 | 1308 / 1809 | 2% | 0.04 | 10 / 472 |
| blood vessel | 70% | 17.12 | 941 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 43% | 7.93 | 523 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 43% | 9.89 | 399 / 929 | 0% | 0 | 0 / 0 |
| heart | 23% | 3.72 | 199 / 861 | 0% | 0 | 0 / 0 |
| liver | 11% | 1.56 | 25 / 226 | 9% | 0.19 | 36 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 0.27 | 5 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.12 | 4 / 45 |
| muscle | 2% | 0.24 | 13 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
| GO_0060292 | Biological process | long-term synaptic depression |
| GO_0099566 | Biological process | regulation of postsynaptic cytosolic calcium ion concentration |
| GO_0150048 | Cellular component | cerebellar granule cell to Purkinje cell synapse |
| GO_0099092 | Cellular component | postsynaptic density, intracellular component |
| GO_0098688 | Cellular component | parallel fiber to Purkinje cell synapse |
| GO_0045211 | Cellular component | postsynaptic membrane |
| Gene name | GRID2IP |
| Protein name | Grid2 interacting protein Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1) |
| Synonyms | |
| Description | FUNCTION: Postsynaptic scaffolding protein at the parallel fiber-Purkinje cell synapse, where it may serve to link GRID2 with actin cytoskeleton and various signaling molecules. . |
| Accessions | A4D2P6 C9JNS8 ENST00000457091.3 ENST00000435185.5 C9J5F6 ENST00000452113.5 |